Next Infectious Disease Webinar: HIV and HCV Diagnostic Strategies: Updates and Key Challenges
September 19, 2023, 5:00 PM CEST / 8:00 AM PDT
Hear from experts about HIV and HCV testing strategies
In this new Infectious Disease Webinar, Prof. Tayou Tagny and Dr. Hayden will guide us through different HIV and HCV testing contexts. Prof. Tayou Tagny will share how the latest recommendations on HIV testing present some challenges for the confirmation of positive results and Dr. Hayden will share the current CDC position and forward-looking outlook on HCV testing.
Can't make it? Register anyway for the recorded webinar.
Register today
More information:
The screening of anti-HIV and anti-HCV antibodies combined with antigen detection has been the cornerstone in HIV and HCV diagnostic strategies. Today's HIV and HCV screening tests have demonstrated high levels of sensitivity which may sometimes be associated with minimal false positive results. In such cases, confirmatory or supplemental assays are used to avoid misinterpretation that could lead to critical outcomes. Nucleic Acid Testing (NAT), although not readily available everywhere, has reduced the window period after HIV or HCV exposure and is essential as an aid in assessing viral response to antiretroviral treatment. To enhance early diagnosis and effectively guide patients towards treatment and prevention, HIV and HCV screening and confirmation assays and testing strategies continue to evolve. This is complemented by a deeper understanding of diagnostic tools.
